Language:

Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection

Cell Systems, 2020-07, Vol.11 (1), p.11 [Peer Reviewed Journal]

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;ISSN: 2405-4720 ;ISSN: 2405-4712 ;EISSN: 2405-4720 ;DOI: 10.1016/j.cels.2020.05.012

Digital Resources/Online E-Resources

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection
Author: Messner, Christoph B ; Demichev, Vadim ; Wendisch, Daniel ; Michalick, Laura ; White, Matthew ; Freiwald, Anja ; Textoris-Taube, Kathrin ; Vernardis, Spyros I ; Egger, Anna-Sophia ; Kreidl, Marco ; Ludwig, Daniela ; Kilian, Christiane ; Agostini, Federica ; Zelezniak, Aleksej ; Thibeault, Charlotte ; Pfeiffer, Moritz ; Hippenstiel, Stefan ; Hocke, Andreas ; Christof von Kalle ; Campbell, Archie ; Hayward, Caroline ; Porteous, David J ; Marioni, Riccardo E ; Langenberg, Claudia ; Lilley, Kathryn S ; Kuebler, Wolfgang M ; Mülleder, Michael ; Drosten, Christian ; Witzenrath, Martin ; Kurth, Florian ; Sander, Leif Erik ; Ralser, Markus
Subjects: antiviral immune response ; clinical classifiers ; COVID-19 infection ; high-throughput proteomics ; mass spectrometry ; SWATH-MS
Is Part Of: Cell Systems, 2020-07, Vol.11 (1), p.11
Description: The COVID-19 pandemic is an unprecedented global challenge, and point-of-care diagnostic classifiers are urgently required. Here, we present a platform for ultra-high-throughput serum and plasma proteomics that builds on ISO13485 standardization to facilitate simple implementation in regulated clinical laboratories. Our low-cost workflow handles up to 180 samples per day, enables high precision quantification, and reduces batch effects for large-scale and longitudinal studies. We use our platform on samples collected from a cohort of early hospitalized cases of the SARS-CoV-2 pandemic and identify 27 potential biomarkers that are differentially expressed depending on the WHO severity grade of COVID-19. They include complement factors, the coagulation system, inflammation modulators, and pro-inflammatory factors upstream and downstream of interleukin 6. All protocols and software for implementing our approach are freely available. In total, this work supports the development of routine proteomic assays to aid clinical decision making and generate hypotheses about potential COVID-19 therapeutic targets.
Publisher: Amsterdam: Elsevier BV
Language: English
Identifier: ISSN: 2405-4720
ISSN: 2405-4712
EISSN: 2405-4720
DOI: 10.1016/j.cels.2020.05.012
Source: Coronavirus Research Database

Back to results list

Previous Result 12 Next Go to Next page


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection

2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;ISSN: 2405-4720 ;ISSN: 2405-4712 ;EISSN: 2405-4720 ;DOI: 10.1016/j.cels.2020.05.012

Searching Remote Databases, Please Wait